Pharma counsel still wary of non-traditional TMs despite benefits

Max edits Managing IP’s news and analysis and oversees the team of reporters. He also helps chair and present the publication’s events, and commissions expert comment. He reports on all aspects of IP, particularly trademark and copyright matters in Europe.